Skip to content

Gastric Insufflation and Laryngeal Mask Airway

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02097771
Enrollment
Unknown
Registered
2014-03-27
Start date
2014-11-30
Completion date
Unknown
Last updated
2014-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Insufflation

Keywords

laryngeal mask airway ventilation

Brief summary

Comparison of the incidence of gastric insufflation between two kinds of laryngeal masks airways: LMA SupremeTM vs Ambu AuraOnceTM

Interventions

DEVICEAuraOnceTM

Sponsors

Lionel Bouvet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* ASA 1 or 2 * Age \> 18 yrs * Use of laryngeal mask airway required

Exclusion criteria

* risk of pulmonary aspiration of gastric contents * Contraindication for the use of laryngeal mask airway * Tracheal intubation required * Patient's refusal

Design outcomes

Primary

MeasureTime frame
incidence of gastric insufflationduring pulmonary ventilation through the laryngeal mask airway

Countries

France

Contacts

Primary ContactLionel Bouvet
lionel.bouvet@chu-lyon.fr+33 4 72 11 69 88

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026